BSE Live
Sep 09, 16:01Prev. Close
3609.90
Open Price
3638.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 09, 15:48Prev. Close
3612.90
Open Price
3634.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3643.30 (229)
Profit & Loss account of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 6,025.93 | 5,556.72 | 4,141.90 | 4,461.66 | 5,301.65 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 6,025.93 | 5,556.72 | 4,141.90 | 4,461.66 | 5,301.65 | |
Total Operating Revenues | 6,168.44 | 5,762.48 | 4,248.24 | 4,592.68 | 5,439.48 | |
Other Income | 236.93 | 381.96 | 332.31 | 299.60 | 293.14 | |
Total Revenue | 6,405.37 | 6,144.44 | 4,580.55 | 4,892.28 | 5,732.62 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,352.96 | 1,206.95 | 995.25 | 1,176.40 | 1,040.97 | |
Purchase Of Stock-In Trade | 341.32 | 342.76 | 352.79 | 220.99 | 192.15 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -56.83 | -4.97 | -232.35 | -10.95 | -50.36 | |
Employee Benefit Expenses | 1,061.76 | 1,014.06 | 826.07 | 699.04 | 572.10 | |
Finance Costs | 430.49 | 480.97 | 293.68 | 202.38 | 179.83 | |
Depreciation And Amortisation Expenses | 606.66 | 578.90 | 383.88 | 269.36 | 213.41 | |
Other Expenses | 1,552.24 | 1,590.65 | 1,399.10 | 1,380.05 | 1,043.35 | |
Total Expenses | 5,288.60 | 5,209.32 | 4,018.42 | 3,937.27 | 3,191.45 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,116.77 | 935.12 | 562.13 | 955.01 | 2,541.17 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -192.82 | |
Profit/Loss Before Tax | 1,116.77 | 935.12 | 562.13 | 955.01 | 2,348.35 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 192.13 | 193.75 | 121.15 | 222.08 | 495.52 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -13.87 | -4.05 | -41.06 | -121.29 | 109.84 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 178.26 | 189.70 | 80.09 | 100.79 | 605.36 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 938.51 | 745.42 | 482.04 | 854.22 | 1,742.99 | |
Profit/Loss From Continuing Operations | 938.51 | 745.42 | 482.04 | 854.22 | 1,742.99 | |
Profit/Loss For The Period | 938.51 | 745.42 | 482.04 | 854.22 | 1,742.99 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 55.46 | 44.05 | 28.48 | 50.48 | 102.99 | |
Diluted EPS (Rs.) | 55.46 | 44.05 | 28.48 | 50.48 | 102.99 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 609.20 | 304.61 | 219.99 | 169.22 | 698.04 | |
Tax On Dividend | 109.30 | 5.08 | 44.78 | 34.45 | 142.11 | |
Equity Dividend Rate (%) | 640.00 | 340.00 | 280.00 | 280.00 | 700.00 |
01.09.2025
03.08.2025
Chartist Talk: Rahul Ghose sees choppy August for Nifty, expects continued Bank Nifty outperformance
29.07.2025
Accumulate Torrent Pharmaceuticals; target of Rs 4000: Prabhudas Lilladher
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
21.05.2025
Torrent Pharma Standalone March 2025 Net Sales at Rs 2,433.00 crore, up 13.53% Y-o-Y
28.01.2025
Torrent Pharma Consolidated December 2024 Net Sales at Rs 2,809.00 crore, up 2.82% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012